BesaGov

Contract 75D30125D00195

Merck Sharp & Dohme Llc · Department Of Health And Human Services · August 26, 2025

Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)Full & Open CompetitionNAICS 325412

Merck Sharp & Dohme Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 26, 2025 for $1.40 billion of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on February 5, 2026. If all options are exercised, the contract could reach $4.38 billion.

Obligated to date
$1.40B
$1,396,845,887
Potential value
$4.38B
if all options exercised
Modifications
5
Latest February 5, 2026

Contract details

PIID
75D30125D00195
Award type
—
Pricing
Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
Drugs And Biologicals
First action
August 26, 2025
Latest action
February 5, 2026

Description

VACCINES FOR CHILDREN FY25

Modification timeline

  • February 5, 2026
    Mod P00008 · Funding Only Action
    $2.46B
  • October 31, 2025
    Mod P00007 · Funding Only Action
    $2.19B
  • September 26, 2025
    Mod P00006 · Other Administrative Action
    $1.94B
  • September 24, 2025
    Mod P00005 · Supplemental Agreement For Work Within Scope
    $1.94B
  • September 22, 2025
    Mod P00004 · Supplemental Agreement For Work Within Scope
    $1.85B
  • August 26, 2025
    Mod P00003 · Funding Only Action
    $1.69B
Sign up free to see all 6 modifications

Similar contracts

RecipientAgencyDateObligated
Four Points Technology, L.L.C.Department Of Health And Human ServicesMarch 31, 2026$246.6K
Astrazeneca Pharmaceuticals LpDepartment Of Health And Human ServicesMarch 31, 2026$122.8K
Emergent Biosolutions Canada IncDepartment Of Health And Human ServicesMarch 30, 2026$256.40M
Mckesson CorporationDepartment Of Health And Human ServicesMarch 30, 2026$9.00M
Ase Direct, Inc.Department Of Health And Human ServicesMarch 30, 2026$49.0K
Pfizer IncDepartment Of Health And Human ServicesMarch 27, 2026$187.56M

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation1,187$4.96B
2Merck Sharp & Dohme Llc26$894.71M
3Sanofi Vaccines Us Inc.57$702.38M
4Pfizer Inc169$541.15M
5Glaxosmithkline, Llc14$505.04M
6Phlow Corp.1$105.27M
7Exelan Pharmaceuticals Inc76$104.30M
8Seqirus USA Inc47$59.15M
9Emergent Biosolutions Canada Inc2$53.73M
10Mckesson Specialty Distribution Llc1$51.05M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75D30125D00195?

Contract 75D30125D00195 is a federal contract awarded to Merck Sharp & Dohme Llc by Department Of Health And Human Services on August 26, 2025 for $1.40 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 5 times since the base award.

Who won contract 75D30125D00195?

Merck Sharp & Dohme Llc won contract 75D30125D00195 from Department Of Health And Human Services.

How much is contract 75D30125D00195 worth?

Contract 75D30125D00195 has obligated $1.40 billion to date, with a total potential value of $4.38 billion if all options are exercised.